Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
20
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Seabaugh Ramona | Chief Financial Officer | 15 | $0 | $5.0K | 2023-09-28 |
| Doerr Mark Edward | Chief Executive Officer | 8 | $0 | $29.4K | 2023-08-18 |
| Ally Bridge MedAlpha Master Fund L.P. | 10% Owner | 8 | $569.5K | $0 | 2023-06-16 |
| Redmile Group, LLC | Director, 10% Owner | 6 | $0 | $0 | 2023-06-16 |
| Johnson Paul D | Director | 3 | $0 | $0 | 2023-06-15 |
| Stettin Glen D. | Director | 4 | $0 | $0 | 2023-06-15 |
| Kramer Michael R | Director | 4 | $0 | $0 | 2023-06-15 |
| MCGRAW LAURIE | Director | 3 | $0 | $0 | 2023-06-15 |
| Ally Bridge Group (NY) LLC | 10% Owner | 8 | $3.15M | $0 | 2023-03-13 |
| Green Jeremy | Director, 10% Owner | 4 | $0 | $0 | 2022-07-01 |
| Gradwell Gerald | Director | 4 | $0 | $0 | 2022-06-15 |
| Hess Steven | Executive Vice President | 2 | $0 | $0 | 2022-04-08 |
| ABG-WTT Global Life Science Capital Partners GP, L.P. | 10% Owner | 6 | $22.64M | $0 | 2022-04-04 |
| Kilroy Edwin | Chief Executive Officer | 11 | $0 | $0 | 2021-03-22 |
| Prezioso Neil | Chief Pharmacy Officer | 3 | $0 | $0 | 2021-03-22 |
| Ferguson Ryan | Chief Financial Officer | 3 | $0 | $0 | 2021-03-22 |
| Misloski Will | Chief Marketing Officer | 3 | $0 | $0 | 2021-03-22 |
| ABG WTT-MedAvail Ltd | 10% Owner | 14 | $1.13M | $0 | 2020-12-29 |
| Mackay Fraser | Chief Information Officer | 3 | $0 | $0 | 2020-11-17 |
| Rawlins Dave | Chief Commercial Officer | 2 | $0 | $0 | 2020-11-17 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Seabaugh Ramona | Chief Financial Officer | S Sale | 2023-09-28 | 2023-10-02 | 303 | $5.70 | $1.7K | 1,222 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | M Exercise deriv | 2023-09-01 | 2023-10-02 | 680 | — | $0 | 679 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | M Exercise | 2023-09-01 | 2023-10-02 | 680 | — | $0 | 1,525 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | A Award deriv | 2023-08-18 | 2023-08-21 | 57,484 | — | $0 | 57,484 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | A Award deriv | 2023-08-18 | 2023-08-21 | 57,484 | — | $0 | 57,484 | SEC↗ |
| Doerr Mark Edward | Chief Executive Officer | A Award deriv | 2023-08-18 | 2023-08-21 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Doerr Mark Edward | Chief Executive Officer | A Award deriv | 2023-08-18 | 2023-08-21 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Ally Bridge MedAlpha Master Fu | 10% Owner | J Other deriv | 2023-06-16 | 2023-06-21 | 965,130 | — | $0 | 965,130 | SEC↗ |
| Ally Bridge MedAlpha Master Fu | 10% Owner | J Other deriv | 2023-06-16 | 2023-06-21 | 6,818,181 | — | $0 | 6,818,181 | SEC↗ |
| Redmile Group, LLC | Director, 10% Owner | A Award deriv | 2023-06-16 | 2023-06-21 | 38,916,562 | — | $0 | 38,916,562 | SEC↗ |
| Redmile Group, LLC | Director, 10% Owner | A Award deriv | 2023-06-16 | 2023-06-21 | 38,916,562 | — | $0 | 38,916,562 | SEC↗ |
| Johnson Paul D | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 545,455 | — | $0 | 545,455 | SEC↗ |
| Stettin Glen D. | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 545,455 | — | $0 | 545,455 | SEC↗ |
| MCGRAW LAURIE | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 545,455 | — | $0 | 545,455 | SEC↗ |
| Kramer Michael R | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 545,455 | — | $0 | 545,455 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | S Sale | 2023-03-21 | 2023-03-23 | 3,287 | $0.31 | $1.0K | 18,319 | SEC↗ |
| Ally Bridge Group (NY) LLC | 10% Owner | P Buy deriv | 2023-03-13 | 2023-03-15 | 965,130 | $0.32 | $308.8K | 965,130 | SEC↗ |
| Ally Bridge Group (NY) LLC | 10% Owner | P Buy deriv | 2023-03-13 | 2023-03-15 | 6,818,181 | $0.32 | $2.18M | 6,818,181 | SEC↗ |
| Redmile Group, LLC | Director, 10% Owner | A Award deriv | 2023-03-09 | 2023-03-13 | 38,916,562 | $0.32 | $12.45M | 38,916,562 | SEC↗ |
| Redmile Group, LLC | Director, 10% Owner | A Award deriv | 2023-03-09 | 2023-03-13 | 38,916,562 | $0.32 | $12.45M | 38,916,562 | SEC↗ |
| Doerr Mark Edward | Chief Executive Officer | S Sale | 2023-03-06 | 2023-03-07 | 72,785 | $0.31 | $22.6K | 188,701 | SEC↗ |
| Doerr Mark Edward | Chief Executive Officer | S Sale | 2023-03-03 | 2023-03-07 | 20,773 | $0.33 | $6.9K | 261,486 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | S Sale | 2023-03-03 | 2023-03-07 | 6,727 | $0.34 | $2.3K | 21,606 | SEC↗ |
| Doerr Mark Edward | Chief Executive Officer | M Exercise deriv | 2023-03-01 | 2023-03-03 | 282,259 | — | $0 | 564,516 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | M Exercise deriv | 2023-03-01 | 2023-03-03 | 8,333 | — | $0 | 16,667 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | M Exercise deriv | 2023-03-01 | 2023-03-03 | 20,000 | — | $0 | 40,000 | SEC↗ |
| Doerr Mark Edward | Chief Executive Officer | M Exercise | 2023-03-01 | 2023-03-03 | 282,259 | — | $0 | 282,259 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | M Exercise | 2023-03-01 | 2023-03-03 | 8,333 | — | $0 | 8,333 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | M Exercise | 2023-03-01 | 2023-03-03 | 20,000 | — | $0 | 28,333 | SEC↗ |
| Green Jeremy | Director, 10% Owner | A Award deriv | 2022-07-01 | 2022-07-06 | 3,819,558 | — | $0 | 9,548,897 | SEC↗ |
| Green Jeremy | Director, 10% Owner | A Award deriv | 2022-07-01 | 2022-07-06 | 4,705,881 | — | $0 | 12,069,628 | SEC↗ |
| Green Jeremy | Director, 10% Owner | A Award | 2022-07-01 | 2022-07-06 | 9,411,765 | $1.06 | $9.98M | 34,604,516 | SEC↗ |
| Green Jeremy | Director, 10% Owner | A Award | 2022-07-01 | 2022-07-06 | 7,639,117 | $1.06 | $8.10M | 19,097,796 | SEC↗ |
| MCGRAW LAURIE | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 116,505 | — | $0 | 116,505 | SEC↗ |
| Johnson Paul D | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 116,505 | — | $0 | 116,505 | SEC↗ |
| Gradwell Gerald | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 116,505 | — | $0 | 116,505 | SEC↗ |
| Stettin Glen D. | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 116,505 | — | $0 | 116,505 | SEC↗ |
| Kramer Michael R | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 116,505 | $1.45 | $168.9K | 116,505 | SEC↗ |
| Hess Steven | Executive Vice President | A Award deriv | 2022-04-08 | 2022-04-12 | 131,000 | — | $0 | 131,000 | SEC↗ |
| Hess Steven | Executive Vice President | A Award deriv | 2022-04-08 | 2022-04-12 | 131,000 | — | $0 | 131,000 | SEC↗ |
| ABG-WTT Global Life Science Ca | 10% Owner | P Buy deriv | 2022-04-04 | 2022-04-06 | 5,571,764 | $1.06 | $5.91M | 5,571,764 | SEC↗ |
| ABG-WTT Global Life Science Ca | 10% Owner | P Buy deriv | 2022-04-04 | 2022-04-06 | 1,487,058 | $1.06 | $1.58M | 1,487,058 | SEC↗ |
| Redmile Group, LLC | Director, 10% Owner | A Award deriv | 2022-04-04 | 2022-04-06 | 7,058,821 | — | $0 | 7,058,821 | SEC↗ |
| ABG-WTT Global Life Science Ca | 10% Owner | P Buy | 2022-04-04 | 2022-04-06 | 2,974,117 | $1.06 | $3.15M | 5,894,897 | SEC↗ |
| ABG-WTT Global Life Science Ca | 10% Owner | P Buy | 2022-04-04 | 2022-04-06 | 11,143,529 | $1.06 | $11.81M | 15,029,480 | SEC↗ |
| Redmile Group, LLC | Director, 10% Owner | A Award | 2022-04-04 | 2022-04-06 | 14,117,646 | $1.06 | $14.96M | 25,192,751 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | A Award deriv | 2022-03-16 | 2022-03-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | A Award deriv | 2022-03-16 | 2022-03-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Johnson Paul D | Director | A Award deriv | 2022-03-16 | 2022-03-18 | 86,372 | — | $0 | 86,372 | SEC↗ |
| MCGRAW LAURIE | Director | A Award deriv | 2022-03-16 | 2022-03-18 | 86,372 | — | $0 | 86,372 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | A Award deriv | 2022-02-09 | 2022-02-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Seabaugh Ramona | Chief Financial Officer | A Award deriv | 2022-02-09 | 2022-02-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Doerr Mark Edward | Chief Executive Officer | A Award deriv | 2022-01-10 | 2022-01-12 | 1,173,127 | — | $0 | 1,173,127 | SEC↗ |
| Doerr Mark Edward | Chief Executive Officer | A Award deriv | 2022-01-10 | 2022-01-12 | 846,775 | — | $0 | 846,775 | SEC↗ |
| Stettin Glen D. | Director | A Award deriv | 2021-06-30 | 2021-07-02 | 18,438 | — | $0 | 18,438 | SEC↗ |
| Kramer Michael R | Director | A Award deriv | 2021-06-30 | 2021-07-02 | 18,438 | — | $0 | 18,438 | SEC↗ |
| Gradwell Gerald | Director | A Award deriv | 2021-06-30 | 2021-07-02 | 18,438 | — | $0 | 18,438 | SEC↗ |
| Prezioso Neil | Chief Pharmacy Officer | A Award deriv | 2021-03-22 | 2021-03-25 | 18,794 | — | $0 | 198,498 | SEC↗ |
| Prezioso Neil | Chief Pharmacy Officer | A Award deriv | 2021-03-22 | 2021-03-25 | 3,465 | — | $0 | 201,963 | SEC↗ |
| Misloski Will | Chief Marketing Officer | A Award deriv | 2021-03-22 | 2021-03-25 | 2,145 | — | $0 | 202,405 | SEC↗ |
| Misloski Will | Chief Marketing Officer | A Award deriv | 2021-03-22 | 2021-03-25 | 11,634 | — | $0 | 200,260 | SEC↗ |
| Ferguson Ryan | Chief Financial Officer | A Award deriv | 2021-03-22 | 2021-03-25 | 2,821 | — | $0 | 267,444 | SEC↗ |
| Ferguson Ryan | Chief Financial Officer | A Award deriv | 2021-03-22 | 2021-03-25 | 15,304 | — | $0 | 264,623 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2021-03-22 | 2021-03-25 | 5,897 | — | $0 | 914,604 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2021-03-22 | 2021-03-25 | 31,984 | — | $0 | 908,707 | SEC↗ |
| Gradwell Gerald | Director | A Award deriv | 2021-01-06 | 2021-01-08 | 14,165 | — | $0 | 215,815 | SEC↗ |
| Stettin Glen D. | Director | A Award deriv | 2021-01-06 | 2021-01-08 | 14,165 | — | $0 | 14,165 | SEC↗ |
| Kramer Michael R | Director | A Award deriv | 2021-01-06 | 2021-01-08 | 14,165 | — | $0 | 14,165 | SEC↗ |
| ABG-WTT Global Life Science Ca | 10% Owner | P Buy | 2020-12-31 | 2021-01-05 | 6,943 | $15.00 | $104.1K | 3,885,951 | SEC↗ |
| ABG-WTT Global Life Science Ca | 10% Owner | P Buy | 2020-12-31 | 2021-01-05 | 5,727 | $15.00 | $85.9K | 2,920,780 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-29 | 2020-12-30 | 55 | $14.00 | $770 | 3,879,008 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-29 | 2020-12-30 | 45 | $14.00 | $630 | 2,915,053 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-28 | 2020-12-30 | 3,894 | $13.98 | $54.4K | 3,878,953 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-28 | 2020-12-30 | 3,213 | $13.98 | $44.9K | 2,915,008 | SEC↗ |
| Ally Bridge Group (NY) LLC | 10% Owner | P Buy | 2020-12-24 | 2020-12-28 | 4,019 | $13.99 | $56.2K | 2,911,795 | SEC↗ |
| Ally Bridge Group (NY) LLC | 10% Owner | P Buy | 2020-12-24 | 2020-12-28 | 4,871 | $13.99 | $68.1K | 3,875,059 | SEC↗ |
| Ally Bridge Group (NY) LLC | 10% Owner | P Buy | 2020-12-23 | 2020-12-28 | 9,810 | $13.99 | $137.2K | 2,907,776 | SEC↗ |
| Ally Bridge Group (NY) LLC | 10% Owner | P Buy | 2020-12-23 | 2020-12-28 | 11,890 | $13.99 | $166.3K | 3,870,188 | SEC↗ |
| Ally Bridge Group (NY) LLC | 10% Owner | P Buy | 2020-12-22 | 2020-12-28 | 9,287 | $13.70 | $127.2K | 3,858,298 | SEC↗ |
| Ally Bridge Group (NY) LLC | 10% Owner | P Buy | 2020-12-22 | 2020-12-28 | 7,661 | $13.70 | $105.0K | 2,897,966 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-21 | 2020-12-22 | 7,358 | $13.31 | $97.9K | 2,890,305 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-21 | 2020-12-22 | 8,919 | $13.31 | $118.7K | 3,849,011 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-18 | 2020-12-22 | 10,192 | $13.59 | $138.5K | 3,840,092 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-18 | 2020-12-22 | 8,408 | $13.59 | $114.3K | 2,882,947 | SEC↗ |
| Ally Bridge MedAlpha Master Fu | 10% Owner | P Buy | 2020-12-17 | 2020-12-18 | 1,029 | $14.00 | $14.4K | 2,874,539 | SEC↗ |
| Ally Bridge MedAlpha Master Fu | 10% Owner | P Buy | 2020-12-17 | 2020-12-18 | 1,248 | $14.00 | $17.5K | 3,829,900 | SEC↗ |
| Ally Bridge MedAlpha Master Fu | 10% Owner | P Buy | 2020-12-17 | 2020-12-18 | 5,731 | $13.12 | $75.2K | 2,873,510 | SEC↗ |
| Ally Bridge MedAlpha Master Fu | 10% Owner | P Buy | 2020-12-17 | 2020-12-18 | 6,946 | $13.12 | $91.1K | 3,828,652 | SEC↗ |
| Ally Bridge MedAlpha Master Fu | 10% Owner | P Buy | 2020-12-16 | 2020-12-18 | 12,851 | $13.06 | $167.8K | 2,867,779 | SEC↗ |
| Ally Bridge MedAlpha Master Fu | 10% Owner | P Buy | 2020-12-16 | 2020-12-18 | 15,578 | $13.06 | $203.4K | 3,821,706 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-15 | 2020-12-16 | 5,184 | $12.50 | $64.8K | 3,795,186 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-15 | 2020-12-16 | 4,276 | $12.50 | $53.5K | 2,845,901 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-15 | 2020-12-16 | 9,027 | $13.08 | $118.1K | 2,854,928 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-15 | 2020-12-16 | 10,942 | $13.08 | $143.1K | 3,806,128 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-14 | 2020-12-16 | 7,922 | $12.24 | $97.0K | 3,790,002 | SEC↗ |
| ABG WTT-MedAvail Ltd | 10% Owner | P Buy | 2020-12-14 | 2020-12-16 | 6,535 | $12.24 | $80.0K | 2,841,625 | SEC↗ |
| Misloski Will | Chief Marketing Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 188,626 | — | $0 | 188,626 | SEC↗ |
| Ferguson Ryan | Chief Financial Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 249,319 | — | $0 | 249,319 | SEC↗ |
| Prezioso Neil | Chief Pharmacy Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 179,704 | — | $0 | 179,704 | SEC↗ |
| Gradwell Gerald | Director | A Award deriv | 2020-11-17 | 2020-11-18 | 201,650 | — | $0 | 201,650 | SEC↗ |
| Rawlins Dave | Chief Commercial Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 224,630 | — | $0 | 224,630 | SEC↗ |
| Rawlins Dave | Chief Commercial Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 74,320 | — | $0 | 298,950 | SEC↗ |
| Mackay Fraser | Chief Information Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 48,559 | — | $0 | 113,175 | SEC↗ |
| Mackay Fraser | Chief Information Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 16,876 | — | $0 | 64,616 | SEC↗ |
| Mackay Fraser | Chief Information Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 47,740 | — | $0 | 47,740 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 127,171 | — | $0 | 628,714 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 5,136 | — | $0 | 834,398 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 92,160 | — | $0 | 829,262 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 108,388 | — | $0 | 737,102 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 42,325 | — | $0 | 876,723 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 81,715 | — | $0 | 501,543 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 350,811 | — | $0 | 419,828 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 28,512 | — | $0 | 69,017 | SEC↗ |
| Kilroy Edwin | Chief Executive Officer | A Award deriv | 2020-11-17 | 2020-11-18 | 40,505 | — | $0 | 40,505 | SEC↗ |